Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Galderma R&D
This study is a follow-up to RD.03.SPR.29074 - ACCESS I / NCT00688064 - "Adapalene-BPO Gel Associated With Doxycycline 100 mg in the Treatment of Severe Acne Vulgaris"
Age
12–35
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who completed the previous study (RD.03.SPR29074 - NCT00688064)and had obtained at least a good Improvement (Grade, 0, 1, 2 or 3)
You may not be if
Female Subjects who are pregnant, nursing or planning a pregnancy during the study
Subjects who foresee intensive UV exposure during the study (mountain sports, UV radiation, sunbathing, etc).
Clareo Health | Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
